Cannabis  

What Metric Jim Cramer Watches in Every Cannabis Earnings Report

What Metric Jim Cramer Watches in Every Cannabis Earnings Report

The Fed's March Meeting: 3 Things Stock Investors Should Look Out For

The Fed's March Meeting: 3 Things Stock Investors Should Look Out For

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Cause for Caution? Top Executives Selling Tilray Stock

Cause for Caution? Top Executives Selling Tilray Stock

With Tilray, You Won't Win Any Valuation Arguments

With Tilray, You Won't Win Any Valuation Arguments

Another Hemp Play to Consider: Charlotte's Web Holdings

Another Hemp Play to Consider: Charlotte's Web Holdings

How Jim Cramer Felt About Tilray's Earnings Call

How Jim Cramer Felt About Tilray's Earnings Call

Tilray Touts Global Ambition as Erosion of Canadian Market Expected

Tilray Touts Global Ambition as Erosion of Canadian Market Expected

Jim Cramer: Tilray's Earnings, Bristol-Myers and Celgene and Elon Musk

Jim Cramer: Tilray's Earnings, Bristol-Myers and Celgene and Elon Musk

Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space

Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space